Skip to main content
Log in

Possible effects of progesterone on human central nervous system and neurogenic tumors

  • Opinion
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Inoue T, Akahira. J, Takeyama J, et al. Spatial and topological distribution of progesterone receptor A and B isoforms during human development. Mol Cell Endocrinol 2001, 182: 83–9.

    Article  CAS  PubMed  Google Scholar 

  2. Baulieu EE, Robel P. Neurosteroids: a new brain function? J Steroid Biochem Mol Biol 1990, 37: 395–403.

    Article  CAS  PubMed  Google Scholar 

  3. Robel P, Baulieu EE. Neurosteroids: biosynthesis and function. Crit Rev Neurobiol 1995, 9: 383–94.

    CAS  PubMed  Google Scholar 

  4. Inoue T, Akahira J, Suzuki T, et al. Progesterone production and actions in the human central nervous system and neurogenic tumors. J Clin Endocrinol Metab 2002, 87: 5325–31.

    Article  CAS  PubMed  Google Scholar 

  5. Koenig HL, Schumacher M, Ferzaz B, et al. Progesterone synthesis and myelin formation by Schwann cells. Science 1995, 268: 1500–3.

    Article  CAS  PubMed  Google Scholar 

  6. Schumacher M, Robel P, Baulieu EE. Development and regeneration of the nervous system: a role for neurosteroids. Dev Neurosci 1996, 18: 6–21.

    Article  CAS  PubMed  Google Scholar 

  7. Lachance Y, Luu-The V, Verreault H, et al. Structure of the human type II 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase (3 beta-HSD) gene: adrenal and gonadal specificity. DNA Cell Biol 1991, 10: 701–11.

    Article  CAS  PubMed  Google Scholar 

  8. Waterman MR. A rising StAR: an essential role in cholesterol transport. Science 1995, 267: 1780–1.

    Article  CAS  PubMed  Google Scholar 

  9. Baulieu EE. Neurosteroids: of the nervous system, by the nervous system, for the nervous system. Recent Prog Horm Res 1997, 52: 1–32.

    CAS  PubMed  Google Scholar 

  10. Chan JR, Phillips LJ. 2nd, Glaser M. Glucocorticoids and progestins signal the initiation and enhance the rate of myelin formation. Proc Natl Acad Sci U S A 1998, 95: 10459–64.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  11. Horwitz KB, Alexander PS. In situ photolinked nuclear progesterone receptors of human breast cancer cells: subunit molecular weights after transformation and translocation. Endocrinology 1983, 113: 2195–201.

    Article  CAS  PubMed  Google Scholar 

  12. Kastner P, Krust A, Turcotte B, et al. Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. Embo J 1990, 9: 1603–14.

    CAS  PubMed Central  PubMed  Google Scholar 

  13. Vegeto E, Shahbaz MM, Wen D, Goldman ME, O’Malley BW, McDonnell DP. Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function [see comments]. Mol Endocrinol 1993, 7: 1244–55.

    CAS  PubMed  Google Scholar 

  14. Sartorius CA, Melville MY, Hovland AR, Tung L, Takimoto GS, Horwitz KB. A third transactivation function (AF3) of human progesterone receptors located in the unique Nterminal segment of the B-isoform. Mol Endocrinol 1994, 8: 1347–60.

    CAS  PubMed  Google Scholar 

  15. Kraus WL, Weis KE, Katzenellenbogen BS. Inhibitory crosstalk between steroid hormone receptors: differential targeting of estrogen receptor in the repression of its transcriptional activity by agonist- and antagonist-occupied progestin receptors. Mol Cell Biol 1995, 15: 1847–57.

    CAS  PubMed Central  PubMed  Google Scholar 

  16. McDonnell DP, Goldman ME. RU486 exerts antiestrogenic activities through a novel progesterone receptor A formmediated mechanism. J Biol Chem 1994, 269: 11945–9.

    CAS  PubMed  Google Scholar 

  17. McDonnell DP, Shahbaz MM, Vegeto E, Goldman ME. The human progesterone receptor A-form functions as a transcriptional modulator of mineralocorticoid receptor transcriptional activity. J Steroid Biochem Mol Biol 1994, 48: 425–32.

    Article  CAS  PubMed  Google Scholar 

  18. Rausing A, Ybo W, Stenflo J. Intracranial meningioma—a population study of ten years. Acta Neurol Scand 1970, 46: 102–10.

    Article  CAS  PubMed  Google Scholar 

  19. Michelsen JJ, New PF. Brain tumour and pregnancy. J Neurol Neurosurg Psychiatry 1969, 32: 305–7.

    CAS  PubMed Central  PubMed  Google Scholar 

  20. Hilbig A, Barbosa-Coutinho LM. Meningiomas and hormonal receptors. Immunohistochemical study in typical and non-typical tumors. Arq Neuropsiquiatr 1998, 56: 193–9.

    Article  CAS  PubMed  Google Scholar 

  21. Carroll RS, Zhang J, Dashner K, Sar M, Black PM. Steroid hormone receptors in astrocytic neoplasms. Neurosurgery 1995, 37: 496–503; discussion 503-4.

    Article  CAS  PubMed  Google Scholar 

  22. Hsu DW, Efird JT, Hedley-Whyte ET. Progesterone and estrogen receptors in meningiomas: prognostic considerations. J Neurosurg 1997, 86: 113–20.

    Article  CAS  PubMed  Google Scholar 

  23. Fewings PE, Battersby RD, Timperley WR. Long-term follow up of progesterone receptor status in benign meningioma: a prognostic indicator of recurrence? J Neurosurg 2000, 92: 401–5.

    Article  CAS  PubMed  Google Scholar 

  24. Khalid H, Shibata S, Kishikawa M, Yasunaga A, Iseki M, Hiura T. Immunohistochemical analysis of progesterone receptor and Ki-67 labeling index in astrocytic tumors. Cancer 1997, 80: 2133–40.

    Article  CAS  PubMed  Google Scholar 

  25. Assimakopoulou M, Sotiropoulou-Bonikou G, Maraziotis T, Varakis J. Does sex steroid receptor status have any prognostic or predictive significance in brain astrocytic tumors? Clin Neuropathol 1998, 17: 27–34.

    CAS  PubMed  Google Scholar 

  26. Viville B, Charnock-Jones DS, Sharkey AM, Wetzka B, Smith SK. Distribution of the A and B forms of the progesterone receptor messenger ribonucleic acid and protein in uterine leiomyomata and adjacent myometrium. Hum Reprod 1997, 12: 815–22.

    Article  CAS  PubMed  Google Scholar 

  27. Kumar NS, Richer J, Owen G, Litman E, Horwitz KB, Leslie KK. Selective down-regulation of progesterone receptor isoform B in poorly differentiated human endometrial cancer cells: implications for unopposed estrogen action. Cancer Res 1998, 58: 1860–5.

    CAS  PubMed  Google Scholar 

  28. Leslie KK, Kumar NS, Richer J, et al. Differential expression of the A and B isoforms of progesterone receptor in human endometrial cancer cells. Only progesterone receptor B is induced by estrogen and associated with strong transcriptional activation. Ann N Y Acad Sci 1997, 828: 17–26.

    Article  CAS  PubMed  Google Scholar 

  29. Akahira J, Inoue T, Suzuki T, et al. Progesterone receptor isoforms A and B in human epithelial ovarian carcinoma: immunohistochemical and RT-PCR studies. Br J Cancer 2000, 83: 1488–94.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  30. Ariga N, Suzuki T, Moriya T, et al. Progesterone receptor A and B isoforms in the human breast and its disorders. Jpn J Cancer Res 2001, 92: 302–8.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tsukasa Inoue.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Inoue, T., Sasano, H. Possible effects of progesterone on human central nervous system and neurogenic tumors. J Endocrinol Invest 27, 76–79 (2004). https://doi.org/10.1007/BF03350916

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03350916

Key-words

Navigation